AQTIS Medicalâ„¢, a Sinclair company Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Utrecht, Utr Netherlands
Total Funding:N/A
Industry:Medical Equip
Founded:2006
Lead Investor(s):N/A

Estimated Revenue & Financials

  • AQTIS Medicalâ„¢, a Sinclair company's estimated annual revenue is currently $12.8M per year.(?)
  • AQTIS Medicalâ„¢, a Sinclair company's estimated revenue per employee is $251,000

Employee Data

  • AQTIS Medicalâ„¢, a Sinclair company has 51 Employees.(?)
  • AQTIS Medicalâ„¢, a Sinclair company grew their employee count by 16% last year.
  • AQTIS Medicalâ„¢, a Sinclair company currently has 1 job openings.

AQTIS Medical™, a Sinclair company, specializes in the research, development, manufacturing and commercialization of innovative injectable medical devices, specifically designed for minimal invasive therapies within medical aesthetics and other therapeutic areas. The focus is on medical devices that are used by physicians to enhance patients’ quality of life and well-being. AQTIS Medical™, a Sinclair company, specializes in the research and development, manufacturing and commercialization of innovative injectable medical devices. Our unique proprietary technology platform is the basis of our bioresorbable medical polymer and gel formulations, including the Ellansé™ dermal filler Family. AQTIS Medical™ has a distinctive competence in the modification and functionalization of bioresorbable polymers and gels in relation to longevity and other desired performance specifications. Its proprietary STAT Technology™ consists of a unique set of bioresorbable medical polymer and gel formulations. Specialities AQTIS Medical™ focuses on setting new standards within the bioresorbable medical aesthetics industry and its innovative cutting-edge technology and superior product quality, performance and service. Our first product-line, the Ellansé™ Family is a range of dermal fillers intended for aesthetic medicine and surgery. The Ellansé™ Family is CE-marked and therefore its safety and performance are approved. Ellansé™ is in compliance with the highest-quality European safety standards for Implantable Medical Devices. Ellansé™ line extensions, based on STAT Technology™, are in different stages of development and will be brought to the market in the future.

keywords:N/A